MONOCYCLIC PYRIDINE DERIVATIVE
The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-cont...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | OHASHI Isao YAMANE Yoshinobu KAROJI Yuki FUNASAKA Setsuo OKADA Toshimi TANAKA Keigo NAGAO Satoshi NAKATANI Yusuke |
| description | The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof:
wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-containing non-aromatic heterocycle; R 1 represents an alkoxy group, an alkoxy alkoxy group or the like; R 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R 3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like; and R 4 represents a C 1-6 alkyl group, with the proviso that when E represents an azetidine ring and R 2 or R 3 is present on a nitrogen atom on the azetidine ring, the R 2 or R 3 does not represent a hydrogen atom. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2960238TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2960238TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2960238TT13</originalsourceid><addsrcrecordid>eNrjZJDz9ffzd4509vF0VgiIDPJ08fRzVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ5GlmYGRsYWISGGxsSoAQDVEiIO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MONOCYCLIC PYRIDINE DERIVATIVE</title><source>esp@cenet</source><creator>OHASHI Isao ; YAMANE Yoshinobu ; KAROJI Yuki ; FUNASAKA Setsuo ; OKADA Toshimi ; TANAKA Keigo ; NAGAO Satoshi ; NAKATANI Yusuke</creator><creatorcontrib>OHASHI Isao ; YAMANE Yoshinobu ; KAROJI Yuki ; FUNASAKA Setsuo ; OKADA Toshimi ; TANAKA Keigo ; NAGAO Satoshi ; NAKATANI Yusuke</creatorcontrib><description>The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof:
wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-containing non-aromatic heterocycle; R 1 represents an alkoxy group, an alkoxy alkoxy group or the like; R 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R 3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like; and R 4 represents a C 1-6 alkyl group, with the proviso that when E represents an azetidine ring and R 2 or R 3 is present on a nitrogen atom on the azetidine ring, the R 2 or R 3 does not represent a hydrogen atom.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170731&DB=EPODOC&CC=SI&NR=2960238T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170731&DB=EPODOC&CC=SI&NR=2960238T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OHASHI Isao</creatorcontrib><creatorcontrib>YAMANE Yoshinobu</creatorcontrib><creatorcontrib>KAROJI Yuki</creatorcontrib><creatorcontrib>FUNASAKA Setsuo</creatorcontrib><creatorcontrib>OKADA Toshimi</creatorcontrib><creatorcontrib>TANAKA Keigo</creatorcontrib><creatorcontrib>NAGAO Satoshi</creatorcontrib><creatorcontrib>NAKATANI Yusuke</creatorcontrib><title>MONOCYCLIC PYRIDINE DERIVATIVE</title><description>The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof:
wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-containing non-aromatic heterocycle; R 1 represents an alkoxy group, an alkoxy alkoxy group or the like; R 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R 3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like; and R 4 represents a C 1-6 alkyl group, with the proviso that when E represents an azetidine ring and R 2 or R 3 is present on a nitrogen atom on the azetidine ring, the R 2 or R 3 does not represent a hydrogen atom.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDz9ffzd4509vF0VgiIDPJ08fRzVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ5GlmYGRsYWISGGxsSoAQDVEiIO</recordid><startdate>20170731</startdate><enddate>20170731</enddate><creator>OHASHI Isao</creator><creator>YAMANE Yoshinobu</creator><creator>KAROJI Yuki</creator><creator>FUNASAKA Setsuo</creator><creator>OKADA Toshimi</creator><creator>TANAKA Keigo</creator><creator>NAGAO Satoshi</creator><creator>NAKATANI Yusuke</creator><scope>EVB</scope></search><sort><creationdate>20170731</creationdate><title>MONOCYCLIC PYRIDINE DERIVATIVE</title><author>OHASHI Isao ; YAMANE Yoshinobu ; KAROJI Yuki ; FUNASAKA Setsuo ; OKADA Toshimi ; TANAKA Keigo ; NAGAO Satoshi ; NAKATANI Yusuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2960238TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OHASHI Isao</creatorcontrib><creatorcontrib>YAMANE Yoshinobu</creatorcontrib><creatorcontrib>KAROJI Yuki</creatorcontrib><creatorcontrib>FUNASAKA Setsuo</creatorcontrib><creatorcontrib>OKADA Toshimi</creatorcontrib><creatorcontrib>TANAKA Keigo</creatorcontrib><creatorcontrib>NAGAO Satoshi</creatorcontrib><creatorcontrib>NAKATANI Yusuke</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OHASHI Isao</au><au>YAMANE Yoshinobu</au><au>KAROJI Yuki</au><au>FUNASAKA Setsuo</au><au>OKADA Toshimi</au><au>TANAKA Keigo</au><au>NAGAO Satoshi</au><au>NAKATANI Yusuke</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MONOCYCLIC PYRIDINE DERIVATIVE</title><date>2017-07-31</date><risdate>2017</risdate><abstract>The present invention discloses a compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof:
wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH 2 -; E represents a nitrogen-containing non-aromatic heterocycle; R 1 represents an alkoxy group, an alkoxy alkoxy group or the like; R 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R 3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like; and R 4 represents a C 1-6 alkyl group, with the proviso that when E represents an azetidine ring and R 2 or R 3 is present on a nitrogen atom on the azetidine ring, the R 2 or R 3 does not represent a hydrogen atom.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI2960238TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MONOCYCLIC PYRIDINE DERIVATIVE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OHASHI%20Isao&rft.date=2017-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2960238TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |